Special report

In the midst, as we are, of a major succession event in which trillions of dollars are changing hands between ultra-high-net-worth (UHNW) family members, it has never been more important for every person to feel that they have a voice and, more importantly, feel they are heard.

For many well-established North American family businesses, long-term planning and forward thinking are the hallmarks of their enduring success. However, findings in The North America Family Business Report 2023 from Brightstar Capital Partners and Campden Wealth reveal that a majority of family businesses should address formal succession planning amid fears about a market downturn fueled by higher inflation and rising interest rates.

Throughout his storied career, Dr. David Brown has made significant contributions to medical research within the pharmaceutical industry, but perhaps his most famous innovation came about through a chance observation when the angina medication he was working on had unexpected applications.

While working for Pfizer, he was named co-inventor on the patent for Viagra and, for eight years, led the team that developed the hugely successful erectile dysfunction medication into one of the bonanza breakthroughs of the century.

In a typically bold move that further defines the Rothschilds as a multi-generational international banking family of significant foresight, the French branch of the family are aiming to take their Paris-listed investment bank, Rothschild & Co, private.